Curis (CRIS) FCF Margin (2010 - 2025)
Curis' (CRIS) quarterly FCF Margin came in at 559.84% in Q4 2025, down 28301.0% on a YoY basis from N/an in Q4 2024, and down 219.28% quarter-over-quarter from 175.35% in Q3 2025.
Powered by 
Analysis
Curis (CRIS) FCF Margin (2010 - 2025) Analysis & Trends
Curis (CRIS) has reported FCF Margin for 16 consecutive years, with 559.84% the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 28301.0% year-over-year to 559.84%; the trailing twelve-month figure through Jun 2026 stood at 709.02% (down 44197.0% YoY), and the FY2025 full-year result was 288.05%, up 7464.0% from the prior year.
- FCF Margin eased to 559.84% in Q4 2025 per CRIS's latest filing, from 175.35% in the prior quarter.
- Across five years, FCF Margin topped out at 175.35% in Q3 2025 and bottomed at 817.99% in Q1 2022.
- Historically, FCF Margin has averaged 406.96% across 5 years, with a median of 367.97% in 2023.
- The widest YoY moves for FCF Margin: up 32962 bps in 2025, down 28301 bps in 2025.
- Over 5 years, FCF Margin stood at 260.64% in 2021, then sank by 63 bps to 424.94% in 2022, then gained by 11 bps to 377.82% in 2023, then advanced by 27 bps to 276.83% in 2024, then sank by 102 bps to 559.84% in 2025.
- According to Business Quant data, FCF Margin over the past three periods registered 559.84%, 175.35%, and 291.34% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 14.91% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -22.35% |
| 10 | Curis | 2.63 Mn | -2.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -559.84% |
| Sep 30, 2025 | -175.35% |
| Jun 30, 2025 | -291.34% |
| Mar 31, 2025 | -304.71% |
| Dec 31, 2024 | -276.83% |
| Sep 30, 2024 | -202.52% |
| Jun 30, 2024 | -437.35% |
| Mar 31, 2024 | -634.32% |
| Dec 31, 2023 | -377.82% |
| Sep 30, 2023 | -288.78% |
| Jun 30, 2023 | -358.12% |
| Mar 31, 2023 | -531.08% |
| Dec 31, 2022 | -424.94% |
| Sep 30, 2022 | -466.34% |
| Jun 30, 2022 | -521.73% |
| Mar 31, 2022 | -817.99% |
| Dec 31, 2021 | -260.64% |
| Sep 30, 2021 | -316.22% |
| Jun 30, 2021 | -291.29% |
| Mar 31, 2021 | -602.06% |